Clinical Scorecard: Electroacupuncture as a Complementary Treatment for Drug-Resistant Primary Open-Angle Glaucoma: A Case Report Following CARE Guidelines
At a Glance
Category
Detail
Condition
Key Mechanisms
Elevated intraocular pressure (IOP) is a modifiable risk factor; acupuncture may transiently reduce IOP and enhance ocular perfusion, as supported by preliminary studies.
Target Population
Care Setting
Key Highlights
76-year-old woman with drug-refractory POAG and fluctuating IOP despite quadruple therapy.
Adjunct electroacupuncture initiated; IOP reduction observed after two sessions, with specific values noted.
Best-corrected visual acuity improved from 0.4/0.25 to 0.5 in both eyes after treatment.
No major adverse events reported during the intervention.
Causal attribution of outcomes to electroacupuncture cannot be established due to study design limitations.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Regular monitoring of IOP and visual acuity during treatment, with follow-up every 1-3 months.
Risks
Patient & Prescribing Data
Electroacupuncture may provide short-term IOP stabilization and symptomatic improvement; previous treatments included quadruple therapy with varying efficacy.
Clinical Best Practices
Consider electroacupuncture as an adjunctive treatment for patients with drug-refractory POAG, ensuring thorough diagnostic assessment before initiating treatment.
Educate patients on the limitations and potential benefits of electroacupuncture.
